Trivalvular infective endocarditis secondary to Granulicatella adiacens and Peptostreptococcus spp (original) (raw)
Related papers
Successful treatment of polymicrobial multivalve infective endocarditis
The International Journal of Cardiovascular Imaging, 2007
A 57-year-old man presented with triple valve infective endocarditis. There were vegetations on the tricuspid, mitral, and aortic valve. He had multiple complications such as pulmonary abscess, severe anaemia, and congestive heart failure. His general condition was extremely poor. Intensive medical therapy, such as blood transfusion, mechanical ventilation, and inotropic support, allowed him to tolerate surgery. Triple valve replacement was successfully performed without major complication. Vegetation cultures grew Streptococcus bovis and Enterecoccus faecalis. At 1 year follow-up, the patient is alive in NYHA functional class I.
Infective Endocarditis : A Brief Overview
2015
Bacterial endocarditis is a serious infection of the heart valves caused mainly by Staphylococcus aureus and Streptococcusviridans. The objective of this study was to conduct a literature review of the main guidelines for the AHA and work related to bacterial resistance and the applicability of these standards in clinical cases. It was infective endocarditis. Concluded that, although relatively uncommon, is a disease que causes substantial morbidity and mortality. Although the advances in diagnosis and treatment have improved antimicrobial, prevention is still an important factor.
INFECTIVE ENDOCARDITIS DIAGNOSIS ANTIMICROBIAL THERAPY AND MANAGEMENT
IASET, 2013
Infective Endocarditis (IE) is the inflammation of inner heart tissue and its valves, caused by infecting micro-flora. The median age of patients has increased from 30 years to currently 57.9 years. The disease is uncommon in children unless associated with cardiac defects, surgical procedures or nosocomial catheter related bacteremia. The characteristic lesion of IE is the vegetation, amorphous mass of platelets and fibrin with dense bacteria, and inflammatory cells enmeshed. In IE infecting organisms are viridans group of Streptococci, Streptococci, Staphylococci, HACEK group of organisms and fungi. Diagnosis of IE is by modified Duke Criteria, evidence of infecting bacteria and evidence of endocarditis by two dimensional echocardiography .Treatment of IE with IV bactericidal antibiotics, penicillin, ceftriaxone and an amino glycoside added for Enterococci. Fungal infection may be treated with amphotericin and flucocytosine. IE may be associated with high mortality.
Cureus
Infective endocarditis in the adult is life-threatening. Bacterial endocarditis is an inner infection lining the heart muscle (endocardium). The scientific study of the causes of diseases is known as etiology. The agents that cause disease fall into five groups: bacteria, viruses, protozoa, fungi, and helminths (worms). Risk factors are past heart defects, damaged or abnormal heart valves, new valves after surgery, chronic hemodialysis, and immunosuppressed state (chemotherapy, HIV, etc.). Infective endocarditis is categorized into two clinical forms: bacterial acute and subacute endocarditis. Acute bacterial endocarditis is usually caused by staphylococci (staph) and streptococci (strep). And occasionally by listeria and brucella bacterial strains. Invasive medical technology has increased the responsibility of healthcare-associated infective endocarditis (HAIE). Microscopy of the disease is the chronic aggressive cells in the deeper zone of nonspecific, composed of fibrin and platelets covering colonies of bacteria. Tuberculous valvular endocarditis due to mycobacterium tuberculosis is a rare clinical entity. Syphilitic endocarditis is pathologically the cutaneous lesions of secondary syphilis. It is caused by infection with the microorganismTreponema pallidum. Fungal endocarditis is a rare and fatal condition. They are infected with fungi such as Candida albicans, Histoplasma capsulatum, and Aspergillus species. Fatal endocarditis associated with Q fever (query fever). Q fever is a chronic or prolonged disease caused by the rickettsiallike bacillus Coxiella burnetii, a rare form of rickettsia in the endocarditis. Varicella-zoster virus (VZV) infection causes chronic and repeated febrile illness. They are followed by pharyngitis, malaise, and a vesicular rash. Chronic Q fever usually manifests as endocarditis or hepatitis. The therapy given to simplify the complications is antimicrobial therapy. The medicines prescribed are ampicillin, cefazolin, ceftazidime, gentamicin, vancomycin, metronidazole, and tobramycin. High medicinal antibiotics are used to control the spread of infective endocarditis.
JAMA: The Journal of the American Medical Association, 1995
Objective. To provide guidelines for the treatment of endocarditis in adults caused by the following microorganisms: viridans streptococci and other streptococci, enterococci, staphylococci, and fastidious gram-negative bacilli of the HACEK group. Participants. An ad hoc writing group appointed by the American Heart Association under the auspices of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. Evidence. Published studies of the treatment of patients with endocarditis and the collective clinical experience of this group of experts. Consensus Process. The recommendations were formulated during meetings of the working group and were prepared by a writing committee after the group had agreed on the specific therapeutic regimens. The consensus statement was subsequently reviewed by standing committees of the American Heart Association and by a group of experts not affiliated with the working group. Conclusions. Sufficient evidence has been published that recommendations regarding treatment of the most common microbiological causes of endocarditis (viridans streptococci, enterococci, Streptococcus bovis, staphylococci, and the HACEK organisms) are justified. There are insufficient published data to make a strong statement regarding the efficacy of specific therapeutic regimens for cases of endocarditis due to microorganisms that uncommonly cause endocarditis. As a useful aid to the practicing clinician, the writing group developed a consensus opinion regarding management of endocarditis caused by the most commonly encountered microorganisms and regarding those cases due to infrequent causes of endocarditis.
Medicina
Background and Objectives: Multidrug-resistant microorganisms have made treating bacterial infections challenging. Resistance to antibiotics is expected to overcome efforts to produce new, effective antibacterial medication that is lifesaving in many situations. Infective endocarditis (IE) is a life-threatening infection that affects 5–15 per 100,000 patients annually and requires rapid antibiotic therapy to prevent morbidity and mortality. Materials and Methods: The present research assessed IE cases over five years, from a multicentric database, with the main objective of determining the degree of antibiotic resistance in these patients, stratified by Gram-positive and Gram-negative bacteria. Results: Bad oral hygiene was present in 58.6% of patients from the Gram-negative group (vs. 38.7% in the Gram-positive group). Non-valvular heart disease was identified in approximately 40% of all patients, and valvopathies in approximately 20%. It was observed that 37.9% of Gram-negative IE...